See also this year's filing and all EDGAR filings for this company.
PDF Report 0001072379_2020_NORTHWEST_BIOTHERAPEUTICS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.043314285714285715, 'aggregate_val': 9129000, 'exp_sum': 8750000, 'exp_to_value': {'AssetsCurrent': 3200000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 281000, 'remainder_Assets': 5269000}} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001072379')"} |
info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - Calc 2': 2, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 15}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001072379, NORTHWEST BIOTHERAPEUTICS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 3,200,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 281,000 |
3 | remainder_Assets | 5,648,000 |
4 | LiabilitiesCurrent | 41,194,000 |
5 | LiabilitiesNoncurrent | 11,502,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 12,541,000 |
9 | ResearchAndDevelopmentExpense | 13,590,000 |
10 | remainder_Expenses | 3,742,000 |
11 | remainder_Revenues | 2,410,000 |
12 | remainder_NetIncome | 7,167,000 |
13 | remainder_ComprehensiveNetIncome | -164,000 |
yvar | yval | |
---|---|---|
0 | Assets | 9,129,000 |
1 | Liabilities | 52,696,000 |
2 | Expenses | 29,873,000 |
3 | Revenues | 2,410,000 |
4 | StockholdersEquity | -43,567,000 |
5 | NetIncome | -20,296,000 |
6 | ComprehensiveNetIncome | -20,378,000 |
7 | BaseVar | 50,719,500 |
8 | EconomicCapitalRatio | -3.08 |